Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kate Farnell
Observed names:
Farnell, Kate,
K Farnell,
K. Farnell
Institution:
Freeman Hospital
Observed institutions:
Freeman Hospital,
Breast Cancer Trials,
British Nuclear Medicine Society,
Newcastle Australia Institute of Higher Education,
University of Glasgow
OpenAlex ID:
A5111060376
Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer
2012
·
Ujjal Mallick
, Clive Harmer
, et al.
·
New England Journal of Medicine
·
644
PDF
Results of the Thyroid Cancer Alliance international patient/survivor survey: Psychosocial/informational support needs, treatment side effects and international differences in care
2013
·
Thyroid Cancer Alliance
, Rita Banach
, et al.
·
HORMONES
·
80
Quality of life in differentiated thyroid cancer
2017
·
Charlotte McIntyre
, Thomas Jacques
, et al.
·
International Journal of Surgery
·
65
PDF
Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial
2025
·
Ujjal Mallick
, Kate Newbold
, et al.
·
The Lancet
·
59
PDF
Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial
2019
·
Sarah R. Brown
, Andrew Hall
, et al.
·
BMC Cancer
·
39
PDF
Patient Preparation and Radiation Protection Guidance for Adult Patients Undergoing Radioiodine Treatment for Thyroid Cancer in the UK
2022
·
J. Wadsley
, N. Armstrong
, et al.
·
Clinical Oncology
·
31
PDF
Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy
2023
·
Jon Wadsley
, Gemma Ainsworth
, et al.
·
Thyroid
·
26
PDF
Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice
2023
·
Jaume Capdevila
, Desiree’ Deandreis
, et al.
·
European Thyroid Journal
·
19
PDF
Evaluation and Management of Thyroid Nodules: A Joint Consensus Statement From the British Thyroid Association (BTA), British Association of Endocrine and Thyroid Surgeons (BAETS) and Collaborating Bodies
2026
·
Ram Moorthy
, Saba P. Balasubramanian
, et al.
·
Clinical Endocrinology
·
5
2212MO Major secondary outcomes in the multicentre noninferiority randomised trial IoN: Is ablative radioiodine necessary for low-risk differentiated thyroid cancer patients?
2023
·
A. Hackshaw
, K. Newbold
, et al.
·
Annals of Oncology
·
5
PDF
Quality of life in differentiated thyroid cancer
2017
·
Charlotte McIntyre
, Fausto Palazzo
, et al.
·
European Journal of Surgical Oncology
·
1
Thyroid Cancer: Doctor–Patient Partnership
2010
·
K. Farnell
·
Clinical Oncology
·
1
PDF
Iodine or Not for Low-risk Differentiated Thyroid Cancer: How Should We Implement the Findings into UK Practice? An Expert Consensus Opinion
2025
·
K. Newbold
, N. Armstrong
, et al.
·
Clinical Oncology
PDF
The development and validation of the UK’s first thyroid cancer patient decision aid
2025
·
W Yang
, K Farnell
, et al.
·
British journal of surgery
PDF
A study of variation in therapeutic approach to low-risk differentiated thyroid cancer in the UK
2023
·
Pavithran Maniam
, Hiro Ishii
, et al.
·
The Journal of Laryngology & Otology
Patient and surgeon perspectives on the American Thyroid Association (ATA) 2015 & British Thyroid Association (BTA) 2014 guidelines in the management of “Low-Risk” Thyroid Cancers (LRDTCs): Two sides of the coin
2020
·
Hiro Ishii
, Iain Nixon
, et al.
Reprint of: Seeking patient feedback to inform changes in thyroid cancer services: A Butterfly Thyroid Cancer Trust initiative
2014
·
Kate Farnell
, Abigail Walker
, et al.
·
European Journal of Surgical Oncology
Seeking patient feedback to inform changes in thyroid cancer services: A Butterfly Thyroid Cancer Trust initiative
2014
·
Kate Farnell
, Abigail Walker
, et al.
·
European Journal of Surgical Oncology
A17 Developing services for thyroid cancer patients who require radioactive iodine ablation (131I): the impact of user involvement
2006
·
I. Driver
, M. Vincent
, et al.
·
Nuclear Medicine Communications
Show more works
View as search
Works count:
21
Citation count:
975
H-index:
8
I10-index:
8
Year
Topic
Type